Startups

Clear Guide Medical closes $1.5 million Series A

And another $1.5 million could be on the way. The startup's biopsy imaging tools also have FDA approval.

Clear Guide Medical's SCENERGY and SuperPROBE in action. (Image via YouTube)

A Johns Hopkins spinout has FDA approval and a Series A in hand, and is set to step up sales of its system to improve biopsy imaging.
Clear Guide Medical closed on $1.5 million in new funding, and could double that number with add-on investments in the near future. The round was led by Georgia-based Wildermuth Advisory.
https://twitter.com/ClearGuide/status/720990472647360512
The new money follows FDA approval in February for the company’s imaging product, called SCENERGY. Sold as an accessory to ultrasound machines, it includes a “SuperPROBE” that links an ultrasound’s existing probe with the Clear Guide system. It helps specialists conducting biopsies to work with CT and ultrasound images at the same time. The system also has an automated registration process designed to reduce time.
Formed by a group of Johns Hopkins researchers in 2010, Clear Guide Medical currently works with several hospitals.  The startup is looking to expand sales in the U.S. and Europe.

Before you go...

Please consider supporting Technical.ly to keep our independent journalism strong. Unlike most business-focused media outlets, we don’t have a paywall. Instead, we count on your personal and organizational support.

Our services Preferred partners The journalism fund
Engagement

Join our growing Slack community

Join 5,000 tech professionals and entrepreneurs in our community Slack today!

Trending

The person charged in the UnitedHealthcare CEO shooting had a ton of tech connections

From rejection to innovation: How I built a tool to beat AI hiring algorithms at their own game

Where are the country’s most vibrant tech and startup communities?

Where small business supports shine — and fail — in Baltimore 

Technically Media